This could determine whether immunotherapy resistance is due to a hostile immune phenotype (immune-desert where there is little infiltration of CD8+ cells within the tumour; or immune-excluded, where the T cells are confined to the extreme periphery of a tumour mass) or T-cell exhaustion. This evidence concerns the gene CD8A and neoplasm.